Bristow Group (BRS) Reports Q2 EPS of 4c, Updates FY EPS Guidance
Get Alerts BRS Hot Sheet
Price: $0.29 --0%
Financial Fact:
Net income available to common stockholders: -29.8M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Net income available to common stockholders: -29.8M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Bristow Group (NYSE: BRS) reported Q2 EPS of $0.04, $0.64 worse than the analyst estimate of $0.68. Revenue for the quarter came in at $446.9 million versus the consensus estimate of $447.86 million.
Bristow Group sees FY2016 EPS of $1.80-$2.40, versus prior guidance of $3.10-$3.75 and the consensus of $3.21.
For earnings history and earnings-related data on Bristow Group (BRS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Bragg Gaming Group Inc. (BRAG) Tops Q2 EPS by 2c
- McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share